Tech Company Financing Transactions
Click Therapeutics Funding Round
On 10/26/2021, Click Therapeutics landed $52 million in Series B investment from Accelmed, H.I.G. Capital and Health Catalyst Capital Management.
Transaction Overview
Accelmed (Lead Investor) (Uri Geiger)
H.I.G. Capital (Lead Investor) (Alex Zisson)
Health Catalyst Capital Management
K2 HealthVentures (Parag Shah)
Sanofi-Genzyme BioVentures (Bernard Davitian)
Company Information
New York, NY 10013
USA
Management Team
Browse more venture capital transactions:
Prev: 10/26/2021: Button Finance venture capital transaction
Next: 10/26/2021: Groww venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs